Schott, S. (2017). The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro. OncoTarget, 8(44), . https://doi.org/10.18632/oncotarget.20260
Chicago-Zitierstil (17. Ausg.)Schott, Sarah. "The Conjugated Antimetabolite 5-FdU-ECyd and Its Cellular and Molecular Effects on Platinum-sensitive Vs. -resistant Ovarian Cancer Cells in Vitro." OncoTarget 8, no. 44 (2017). https://doi.org/10.18632/oncotarget.20260.
MLA-Zitierstil (9. Ausg.)Schott, Sarah. "The Conjugated Antimetabolite 5-FdU-ECyd and Its Cellular and Molecular Effects on Platinum-sensitive Vs. -resistant Ovarian Cancer Cells in Vitro." OncoTarget, vol. 8, no. 44, 2017, https://doi.org/10.18632/oncotarget.20260.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.